Myocarditis after BNT162b2 Vaccination in Israeli Adolescents-Reference-Cited by-同舟云学术

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

Published:2022-03-10 Issue:10 Volume:386 Page:998-999
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Mevorach Dror¹,Anis Emilia,Cedar Noa,Hasin Tal²,Bromberg Michal³^ORCID,Goldberg Lital⁴,Parnasa Elchanan¹,Dichtiar Rita,Hershkovitz Yael,Ash Nachman⁴,Green Manfred S.⁵,Keinan-Boker Lital³,Alroy-Preis Sharon⁴

Affiliation:

1. Hadassah Medical Center, Jerusalem, Israel

2. Shaare Zedek Medical Center, Jerusalem, Israel

3. Israel Center for Disease Control, Ramat Gan, Israel

4. Israeli Ministry of Health, Jerusalem, Israel

5. University of Haifa, Haifa, Israel

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2116999

Reference2 articles.

1. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

2. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myopericarditis following COVID-19 vaccination in children: a systematic review and meta-analysis;Singapore Medical Journal;2024-09-03

2. Myocarditis in children 2024, new themes and continued questions;Current Opinion in Cardiology;2024-04-25

3. Pfizer COVID19 vaccine is not associated with acute cardiovascular events excluding myocarditis– a national self-controlled case series study;Israel Journal of Health Policy Research;2024-04-24

4. Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety program;Expert Opinion on Drug Safety;2024-02

5. Covid19 Vaccines Do Not Increase Myocarditis and Pericarditis Incidence: Results from the National Registry of the Italian Society of Cardiology;2024